1 |
Ko, E. J., Ock, M. S., Choi, Y. H., Iovanna, J. L., Mun, S., Han, K., Kim, H. S. and Cha, H. J. 2021. Human Endogenous Retrovirus (HERV)-K env gene knockout affects tumorigenic characteristics of nupr1 gene in DLD-1 colorectal cancer cells. Int. J. Mol. Sci. 22, 3941.
DOI
|
2 |
Ko, E. J., Song, K. S., Ock, M. S., Choi, Y. H., Kim, S., Kim, H. S. and Cha, H. J. 2021. Expression profiles of Human Endogenous Retrovirus (HERV)-K and HERV-R Env proteins in various cancers. BMB Rep. 54, 368-373.
DOI
|
3 |
Laska, M. J., Troldborg, A., Hauge, E. M., Bahrami, S. and Stengaard-Pedersen, K. 2017. Human Endogenous Retroviral genetic element with immunosuppressive activity in both human autoimmune diseases and experimental arthritis. Arthritis Rheumatol. 69, 398-409.
DOI
|
4 |
Clerici, M., Fusi, M. L., Caputo, D., Guerini, F. R., Trabattoni, D., Salvaggio, A., Cazzullo, C. L., Arienti, D., Villa, M. L., Urnovitz, H. B. and Ferrante, P. 1999. Immune responses to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis. J. Neuroimmunol. 99, 173-182.
DOI
|
5 |
Dean, B., Tawadros, N., Scarr, E. and Gibbons, A. S. 2010. Regionally-specific changes in levels of tumour necrosis factor in the dorsolateral prefrontal cortex obtained postmortem from subjects with major depressive disorder. J. Affect. Disord. 120, 245-248.
DOI
|
6 |
Grandi, N. and Tramontano, E. 2018. HERV envelope proteins: physiological role and pathogenic potential in cancer and autoimmunity. Front. Microbiol. 9, 462.
DOI
|
7 |
Groger, V. and Cynis, H. 2018. Human endogenous retroviruses and their putative role in the development of autoimmune disorders such as multiple sclerosis. Front. Microbiol. 9, 265.
DOI
|
8 |
Hahn, S., Ugurel, S., Hanschmann, K. M., Strobel, H., Tondera, C., Schadendorf, D., Lower, J. and Lower, R. 2008. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res. Hum. Retroviruses 24, 717-723.
DOI
|
9 |
Hishikawa, T., Ogasawara, H., Kaneko, H., Shirasawa, T., Matsuura, Y., Sekigawa, I., Takasaki, Y., Hashimoto, H., Hirose, S., Handa, S., Nagasawa, R. and Maruyama, N. 1997. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases. Viral Immunol. 10, 137-147.
DOI
|
10 |
Dembny, P., Newman, A. G., Singh, M., Hinz, M., Szczepek, M., Kruger, C., Adalbert, R., Dzaye, O., Trimbuch, T., Wallach, T., Kleinau, G., Derkow, K., Richard, B. C., Schipke, C., Scheidereit, C., Stachelscheid, H., Golenbock, D., Peters, O., Coleman, M., Heppner, F. L., Scheerer, P., Tarabykin, V., Ruprecht, K., Izsvak, Z., Mayer, J. and Lehnardt, S. 2020. Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors. JCI Insight 5, e131093.
DOI
|
11 |
Stauffer, Y., Marguerat, S., Meylan, F., Ucla, C., Sutkowski, N., Huber, B., Pelet, T. and Conrad, B. 2001. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity 15, 591-601.
DOI
|
12 |
Ariza, M. E. and Williams, M. V. 2011. A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis? J. Invest. Dermatol. 131, 2419-2427.
DOI
|
13 |
Li, M., Radvanyi, L., Yin, B., Rycaj, K., Li, J., Chivukula, R., Lin, K., Lu, Y., Shen, J., Chang, D. Z., Li, D., Johanning, G. L. and Wang-Johanning, F. 2017. Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in pancreatic cancer cells decreases cell proliferation and tumor growth. Clin. Cancer Res. 23, 5892-5911.
DOI
|
14 |
Balada, E., Vilardell-Tarres, M. and Ordi-Ros, J. 2010. Implication of human endogenous retroviruses in the development of autoimmune diseases. Int. Rev. Immunol. 29, 351-370.
DOI
|
15 |
Freimanis, G., Hooley, P., Ejtehadi, H. D., Ali, H. A., Veitch, A., Rylance, P. B., Alawi, A., Axford, J., Nevill, A., Murray, P. G. and Nelson, P. N. 2010. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin. Exp. Immunol. 160, 340-347.
DOI
|
16 |
Moyes, D. L., Martin, A., Sawcer, S., Temperton, N., Worthington, J., Griffiths, D. J. and Venables, P. J. 2005. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86, 337-341.
DOI
|
17 |
Wu, Z., Mei, X., Zhao, D., Sun, Y., Song, J., Pan, W. and Shi, W. 2015. DNA methylation modulates HERV-E expression in CD4+ T cells from systemic lupus erythematosus patients. J. Dermatol. Sci. 77, 110-116.
DOI
|
18 |
Kury, P., Nath, A., Creange, A., Dolei, A., Marche, P., Gold, J., Giovannoni, G., Hartung, H. P. and Perron, H. 2018. Human Endogenous Retroviruses in neurological diseases. Trends Mol. Med. 24, 379-394.
DOI
|
19 |
Douville, R., Liu, J., Rothstein, J. and Nath, A. 2011. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann. Neurol. 69, 141-151.
DOI
|
20 |
Rodrigues, L. S., da Silva Nali, L. H., Leal, C. O. D., Sabino, E. C., Lacerda, E. M., Kingdon, C. C., Nacul, L. and Romano, C. M. 2019. HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndrome. Auto Immun. Highlights 10, 12.
DOI
|
21 |
Tarlinton, R., Wang, B., Morandi, E., Gran, B., Khaiboullin, T., Martynova, E., Rizvanov, A. and Khaiboullina, S. 2019. Differential expression of HERV-W in peripheral blood in multiple sclerosis and healthy patients in two different ethnic groups. Front. Pharmacol. 10, 1645.
DOI
|
22 |
Treger, R. S., Pope, S. D., Kong, Y., Tokuyama, M., Taura, M. and Iwasaki, A. 2019. The Lupus susceptibility locus Sgp3 encodes the suppressor of endogenous retrovirus expression SNERV. Immunity 50, 334-347.e9.
DOI
|
23 |
Wang-Johanning, F., Rycaj, K., Plummer, J. B., Li, M., Yin, B., Frerich, K., Garza, J. G., Shen, J., Lin, K., Yan, P., Glynn, S. A., Dorsey, T. H., Hunt, K. K., Ambs, S. and Johanning, G. L. 2012. Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J. Natl. Cancer Inst. 104, 189-210.
DOI
|
24 |
Boese, A., Sauter, M., Galli, U., Best, B., Herbst, H., Mayer, J., Kremmer, E., Roemer, K. and Mueller-Lantzsch, N. 2000. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19, 4328-4336.
DOI
|
25 |
Yu, H. L., Zhao, Z. K. and Zhu, F. 2013. The role of human endogenous retroviral long terminal repeat sequences in human cancer (Review). Int. J. Mol. Med. 32, 755-762.
DOI
|
26 |
Rolland, A., Jouvin-Marche, E., Viret, C., Faure, M., Perron, H. and Marche, P. N. 2006. The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J. Immunol. 176, 7636-7644.
DOI
|
27 |
Li, W., Lee, M. H., Henderson, L., Tyagi, R., Bachani, M., Steiner, J., Campanac, E., Hoffman, D. A., von Geldern, G., Johnson, K., Maric, D., Morris, H. D., Lentz, M., Pak, K., Mammen, A., Ostrow, L., Rothstein, J. and Nath, A. 2015. Human endogenous retrovirus-K contributes to motor neuron disease. Sci. Transl. Med. 7, 307ra153.
DOI
|
28 |
Morozov, V. A., Morozov, A. V., Semaan, M. and Denner, J. 2012. Single mutations in the transmembrane envelope protein abrogate the immunosuppressive property of HIV-1. Retrovirology 9, 67.
DOI
|
29 |
Portis, J. L. 2002. Perspectives on the role of endogenous human retroviruses in autoimmune diseases. Virology 296, 1-5.
DOI
|
30 |
Saleh, A., Macia, A. and Muotri, A. R. 2019. Transposable elements, inflammation, and neurological disease. Front. Neurol. 10, 894.
DOI
|
31 |
Kawai, T. and Akira, S. 2007. TLR signaling. Semin. Immunol. 19, 24-32.
|
32 |
Mikhalkevich, N., O'Carroll, I. P., Tkavc, R., Lund, K., Sukumar, G., Dalgard, C. L., Johnson, K. R., Li, W., Wang, T., Nath, A. and Iordanskiy, S. 2021. Response of human macrophages to gamma radiation is mediated via expression of endogenous retroviruses. PLoS Pathog. 17, e1009305.
DOI
|
33 |
Hung, T., Pratt, G. A., Sundararaman, B., Townsend, M. J., Chaivorapol, C., Bhangale, T., Graham, R. R., Ortmann, W., Criswell, L. A., Yeo, G. W. and Behrens, T. W. 2015. The Ro60 autoantigen binds endogenous retroelements and regulates inflammatory gene expression. Science 350, 455-459.
DOI
|
34 |
Ishida, T., Obata, Y., Ohara, N., Matsushita, H., Sato, S., Uenaka, A., Saika, T., Miyamura, T., Chayama, K., Nakamura, Y., Wada, H., Yamashita, T., Morishima, T., Old, L. J. and Nakayama, E. 2008. Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun. 8, 15.
|
35 |
Kalunian, K. C., Merrill, J. T., Maciuca, R., McBride, J. M., Townsend, M. J., Wei, X., Davis, J. C. Jr. and Kennedy, W. P. 2016. A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE). Ann. Rheum. Dis. 75, 196-202.
DOI
|